NEW YORK (Reuters Health) - A hand-held device that painlessly sends a magnetic pulse into the head may offer some migraine sufferers relief, a small study suggests. The device delivers a therapy ...
The FDA has granted marketing clearance for eNeura’s single-pulse transcranial magnetic stimulation (sTMS) device for use in patients ≥12 years for the acute and prophylactic treatment of migraine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results